# Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis

> **NCT00503399** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 92 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Risedronate

## Key facts

- **NCT ID:** NCT00503399
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2012-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503399, "Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00503399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*